None
OtterBox Impact Case for iPhone 3G, 3GS (Black)
The OtterBox Impact Series for iPhone 3G / 3GS merges durability, impact absorbing ...
New starting at Too low to display
![Apple iPod touch 8 GB (2nd Generation--with iPhone OS 3.1 Software Installed) [OLD MODEL]](http://ecx.images-amazon.com/images/I/41WgyV%2ByOLL._SL160_.jpg)
Apple iPod touch 8 GB (2nd Generation--with iPhone OS 3.1 Software Installed) [OLD MODEL]
iPod touch is a great iPod, a great pocket computer, and a great portable game player. ...
Used starting at $118.99
New starting at $140.00
![5-Pack Premium Reusable LCD Screen Protector with Lint Cleaning Cloth for Apple iPhone 3G 8GB 16GB [Accessory Export Packaging]](http://ecx.images-amazon.com/images/I/31k022tEKKL._SL160_.jpg)
5-Pack Premium Reusable LCD Screen Protector with Lint Cleaning Cloth for Apple iPhone 3G 8GB 16GB [Accessory Export Packaging]
Item number 180736, Grading is cover/record: VG/EX using Goldmine standards. 1986,2lp ...
New starting at $0.00
OtterBox Defender Case for iPhone 3G, 3G S (Black)
The Otterbox For Apple Iphone 3G Defender Series Case Is Stylish And Slim In Design/ ...
Used starting at $21.98
New starting at Too low to display
Apple iPod touch 32 GB (3rd Generation) OLD MODEL
iPod touch is a great iPod, a great pocket computer, and a great portable game player. ...
Used starting at $189.99
New starting at Too low to display
Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia
Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved ...
HeartWare Receives Second Patient Allotment Under Continued Access Protocol For Pivotal U.S. Bridge-To-Transplant Clinical Trial
HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, ...
Optimer Pharmaceuticals Announces Presentations Of Additional Fidaxomicin Phase 3 Data At Upcoming ICAAC Annual Meeting
Results from studies related to Optimer Pharmaceuticals, Inc.'s (Nasdaq: OPTR) lead developmental ...
Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada
Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company ...
Soligenix Announces Publication Of Article Identifying Domains Within The Ricin Toxin A Subunit As Targets Of Protective Antibodies
Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage ...
Inhibitex Successfully Completes Phase 1a Trial Of INX-189
Inhibitex, Inc. (Nasdaq: INHX), announced that it has successfully completed a Phase1a, ...
Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuPH20 In Type 1 And Type 2 Diabetes
Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast ...
Eisai Announces The Start Of The First Clinical Study Of Ban2401, A Novel Monoclonal Antibody Targeting Neurotoxic Protofibrils
Eisai Co., Ltd. (Headquarters: Tokyo, Japan, President & CEO: Haruo Naito, "Eisai") announced today ...
